Neuroendocrine Tumors Market 2020-Industry Demands, Size & Share, Covid-19 Impact Analysis, Recent Research, Global Growth, Trends, Top Operating Vendors And Forecast To 2026
Global neuroendocrine tumors market is rise gradually to an estimated value of USD 2.80 Billion by 2026 registering a CAGR of 10.2% in the forecast period of 2019-2026. Increasing prevalence of neuroendocrine tumors and accelerating demand of clinical treatment and novel therapies indicates the significant growth of market.
The Neuroendocrine Tumors Market report makes available a thoughtful overview of product specification, technology, product type and production analysis taking into account major factors such as revenue, cost, and gross margin. The report is sure to offer brilliant solution to the challenges and problems faced by industry. This market report comprises of extensive study about miscellaneous market segments and regions, emerging trends, major market drivers, challenges and opportunities in the market. This Neuroendocrine Tumors Market document also displays the key developments in the industry with respect to current scenario and the approaching advancements.
Request for sample copy or PDF Here @ https://www.databridgemarketresearch.com/request-a-sample?dbmr=global-neuroendocrine-tumors-market
This Neuroendocrine Tumors Market analysis report is a cautious investigation of current scenario of the market and future estimations which considers several market dynamics. Market research report acceptance is very essential for the business growth as it helps with the better decision making, enhancing revenue generation, prioritizing market goals & results in profitable business. It makes easy for ABC industry to visualize what is already available in the market, what market anticipates, the competitive environment & what should be done to surpass the competitor. The Neuroendocrine Tumors Market report not only aids to save valuable time but also adds credibility to the work that has been done to grow the business.
Few of the major competitors currently working in the global neuroendocrine tumors market are, Bristol-Myers Squibb Company, Novartis AG, Pfizer Inc., Amgen, Inc., Ipsen Pharma, GlaxoSmithKline Plc, Regeneron Pharmaceuticals, Mylan N.V, Sanofi S.A, Teva Pharmaceutical Industries Ltd, F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Eli Lilly and Company, AbbVie Inc., Advanced Accelerator Applications and among others
Browse Detailed TOC Here @ https://www.databridgemarketresearch.com/toc?dbmr=global-neuroendocrine-tumors-market
Market Definition: Global Neuroendocrine Tumors Market
Neuroendocrine tumors are an oncology disorder in which cancer arises from neuroendocrine cells and proliferate almost all over the body. The organs affected by neuroendocrine tumors are mainly, gastrointestinal (GI) tract, gallbladder, pancreas, lungs and thyroid. It is seen rarely in thymus, kidneys, liver, prostate, skin and ovaries. The patient may experience indigestion, abdominal pain, difficulty in breathing, muscle weakness, jaundice, weight loss etc.
According to the statistics published in American Society of Clinical Oncology, the total prevalent population of neuroendocrine tumors in United States was over 170,000, it is estimated that 12,000 new cases of patients in United States diagnosed with neuroendocrine tumors each year.
Segmentation: Global Neuroendocrine Tumors Market
Neuroendocrine Tumors Market : By Site of Origin
- Carcinoid tumors in the lungs
- Pancreatic neuroendocrine tumors
- Medullary thyroid carcinoma
- Merkel cell carcinoma
- Pheochromocytoma of the adrenal gland
- Small cell lung cancer
- Large cell lung cancer
- Others
Neuroendocrine Tumors Market : By Therapy Type
- Chemotherapy
- Hormonal therapy
- Immunotherapy
- Surgery
- Medication
- Others
Neuroendocrine Tumors Market : By Mechanism of Cation type
- Somatostatin analogs
- Tyrosine kinase inhibitor
- Peptide receptor radionuclide
- Alfa-interferon
- Proton-pump inhibitors
- Others
Neuroendocrine Tumors Market : By Drug Type
- Everolimus
- Sunitinib malate
- Lorlatinib
- Nivolumab
- Dacomitinib
- Brigatinib
- Durvalumab
- Atezolizumab
- Alectinib
- Crizotinib
- Topotecan hydrochloride
- Bevacizumab
- Others
Neuroendocrine Tumors Market : By Route of administration
- Oral
- Intravenous
- Others
Neuroendocrine Tumors Market : By End Users
- Hospitals
- Homecare
- Specialty Clinics
- Others
Neuroendocrine Tumors Market : By Geography
- North America
- South America
- Europe
- Asia-Pacific
- Middle East & Africa
Key Developments in the Market:
- In January 2018, Advanced Accelerator Applications received FDA approval for Lutathera (lutetium Lu 177 dotatate), a radioactive somatostatin receptor acting as a Peptide Receptor Radionuclide Therapy (PRRT), indicated for the treatment of adult patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Previously, drug also received Orphan Drug designation by both the US FDA and European Medicines Agency (EMA)
- In April 2019, Merck & Co., Inc received expanded approval from the US FDA for Keytruda (pembrolizumab), an anti-PD-1 therapy as a first line treatment of patients with stage III non-small cell lung cancer
Reasons to Purchase this Report
- Current and future of global neuroendocrine tumors market outlook in the developed and emerging markets
- The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
- Regions/Countries that are expected to witness the fastest growth rates during the forecast period
- The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report:
- All segmentation provided above in this report is represented at country level
- All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
Report Highlights:
- Shifting Industry dynamics
- In-depth Neuroendocrine Tumors Market segmentation
- Historical, current and projected industry size Recent industry trends
- Key Competition landscape
- Strategies for key players and product offerings
- Potential and niche segments/regions exhibiting promising growth
- A neutral perspective towards market performance
Key Questions Answered in Global Neuroendocrine Tumors Market Report
- What is the scope of growth of companies in the global Neuroendocrine Tumors market?
- What will be the Y-o-Y growth of the global Neuroendocrine Tumors market between 2020 and 2027?
- What is the influence of changing trends in technologies on the global Neuroendocrine Tumors market?
- Will North America continue to be the most profitable market for Neuroendocrine Tumors providers?
- Which factors will hamper the growth of the global Neuroendocrine Tumors market during the forecast period?
- Which are the leading companies in the global Neuroendocrine Tumors market?
Want Full Report? Enquire Here @ https://www.databridgemarketresearch.com/inquire-before-buying?dbmr=global-neuroendocrine-tumors-market
TABLE OF CONTENTS
Part 01: Executive Summary
Part 02: Scope of the Report
Part 03: Research Methodology
Part 04: Market Landscape
• Market Ecosystem
• Market Characteristics
• Market Segmentation Analysis
Part 05: Pipeline Analysis
• Pipeline Analysis
Part 06: Market Sizing
• Market Definition
• Market Sizing
• Market Size And Forecast
Part 07: Five Forces Analysis
• Bargaining Power Of Buyers
• Bargaining Power Of Suppliers
• Threat Of New Entrants
• Threat Of Substitutes
• Threat Of Rivalry
• Market Condition
Part 08: Market Segmentation
• Segmentation
• Comparison
• Market Opportunity
Part 09: Customer Landscape
Part 10: Regional Landscape
• Geographical Segmentation
• Regional Comparison
• North America
• South America
• Europe
• MEA
• APAC
• Market Opportunity
Part 11: Decision Framework
Part 12: Drivers and Challenges
• Market Drivers
• Market Challenges
Part 13: Market Trends
Part 14: Vendor Landscape
• Overview
• Landscape Disruption
Part 15: Vendor Analysis
• Vendors Covered
• Vendor Classification
• Market Positioning Of Vendors
Part 16: Appendix
• List Of Abbreviations
Top Trending Reports :
About Data Bridge Market Research:
Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.We are content with our glorious 99.9 % client satisfying rate.
Contact Us
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Mail: Corporatesales@databridgemarketresearch.com
This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.
Editor Details
-
Company:
- CDN Newswire
